Data from a Nordic register-based study observed a significant increase in risk for autism spectrum disorder and intellectual disability in children with prenatal exposure to topiramate.

The post Prenatal Exposure to Topiramate (Topamax): Impact on Neurodevelopmental Outcomes appeared first on MGH Center for Women’s Mental Health.